Prenetics Global Limited’s Acquisition of Majority Stake in ACT Genomics

Prenetics Global Limited (NASDAQ: PRE) acquired a majority stake in ACT Genomics Holdings Company Limited (“ACT”), an Asia-based genomics company specialising in precision oncology with operations…